A 16-year-old patient with an 8-year history of psoriasis presents to the office with a swollen lip. She reports that her psoriasis is currently being treated with topical steroids and UV light therapy. Can you make the diagnosis?
Potential risk factors associated with cognitive impairment in patients with psoriasis are assessed.
Two patients present with itchy, scaly spots. Can you make the diagnosis?
August and September 2021 FDA drug approvals include treatments for tick-borne encephalitis, idiopathic hypersomnia, schizophrenia, and atopic dermatitis.
Secukinumab vs adalimumab for treatment in patients with concomitant plaque psoriasis and active psoriatic arthritis during 52 weeks is reported.
Individuals with psoriasis/PsA have decreased ability to participate in social roles and activities, more depression symptoms.
A 29-year-old man presents to the dermatology clinic for evaluation of a rash on his body that began 2 weeks ago. Can you make the diagnosis?
At AAD VMX 2021, researchers presented data on skin clearance rates through 5 years with guselkumab in patients with moderate to severe plaque psoriasis.
In moderate-to-severe plaque psoriasis, bimekizumab is noninferior and superior to secukinumab and adalimumab, according to data from 2 studies.
Researchers sought to determine if a higher cumulative pain intensity is associated with premature mortality risk in patients with PsA.
